Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Joram N.I. van Miert"'
Autor:
Sjaam Jainandunsing, H. Rita Koole, Joram N.I. van Miert, Trinet Rietveld, J.L. Darcos Wattimena, Eric J.G. Sijbrands, Felix W.M. de Rooij
Publikováno v:
EBioMedicine, Vol 30, Iss , Pp 295-302 (2018)
Transcription factor 7-like 2 (TCF7L2) is the main susceptibility gene for type 2 diabetes, primarily through impairing the insulin secretion by pancreatic β cells. However, the exact in vivo mechanisms remain poorly understood. We performed a famil
Externí odkaz:
https://doaj.org/article/36e579999d6240f29c3b34791b027624
Autor:
Jacobijne J. Wiersma, Erik S.G. Stroes, Joram N.I. van Miert, Hein J. Verberne, Marijn C. Meuwese, Mieke D. Trip, Jan G.P. Tijssen, Berthe L. F. van Eck-Smit, Jan J. Piek
Publikováno v:
Clinica chimica acta; international journal of clinical chemistry, 412(1-2), 86-90. Elsevier
Background: MPO, an enzyme of the innate immune system, exhibits pro-atherogenic effects. These include oxidative damage to LDL- and HDL-cholesterol, and promotion of endothelial dysfunction. Recent studies revealed that MPO independently predicts ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4e7c454812e7fbedf6aee64448cad72
https://doi.org/10.1016/j.cca.2010.09.019
https://doi.org/10.1016/j.cca.2010.09.019
Autor:
Robert G. Schaub, John J.P. Kastelein, Stanley L. Hazen, Joram N.I. van Miert, Robert Luben, Marijn C. Meuwese, Nicholas J. Wareham, Jan Albert Kuivenhoven, Erik S.G. Stroes, Kay-Tee Khaw, S. Matthijs Boekholdt
Publikováno v:
Journal of the American College of Cardiology. 50:159-165
Objectives We evaluated whether serum myeloperoxidase (MPO) levels are associated with the risk of future development of coronary artery disease (CAD) in apparently healthy individuals. Background An enzyme of the innate immune system, MPO exhibits a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae5bf1afe0a41d213b5ecf57c82da802
https://doi.org/10.1016/j.jacc.2007.03.033
https://doi.org/10.1016/j.jacc.2007.03.033
Autor:
Sheila Bingham, Jaap Rip, S. Matthijs Boekholdt, Robert Luben, Nicholas E. Day, Joram N.I. van Miert, John J.P. Kastelein, Nicholas J. Wareham, Barbara A. Hutten, Melchior C. Nierman, Jan Albert Kuivenhoven, Kay-Tee Khaw
Publikováno v:
Arteriosclerosis, thrombosis, and vascular biology, 26(3), 637-642. Lippincott Williams and Wilkins
Background— Lipoprotein lipase (LPL) is associated with coronary artery disease (CAD) risk, but prospective population data are lacking. This is mainly because of the need for cumbersome heparin injections, which are necessary for LPL measurements.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a466607fa8f13da578fe5d7e8388148
https://doi.org/10.1161/01.atv.0000201038.47949.56
https://doi.org/10.1161/01.atv.0000201038.47949.56